Chelsea Counsel Company’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $485K | Hold |
3,830
| – | – | 0.24% | 68 |
|
|
2025
Q1 | $490K | Hold |
3,830
| – | – | 0.27% | 62 |
|
|
2024
Q4 | $506K | Sell |
3,830
-1,050
| -22% | -$139K | 0.26% | 63 |
|
|
2024
Q3 | $711K | Sell |
4,880
-730
| -13% | -$106K | 0.35% | 59 |
|
|
2024
Q2 | $770K | Sell |
5,610
-100
| -2% | -$13.7K | 0.38% | 52 |
|
|
2024
Q1 | $784K | Hold |
5,710
| – | – | 0.44% | 41 |
|
|
2023
Q4 | $776K | Hold |
5,710
| – | – | 0.41% | 49 |
|
|
2023
Q3 | $699K | Hold |
5,710
| – | – | 0.36% | 58 |
|
|
2023
Q2 | $725K | Buy |
5,710
+130
| +2% | +$16.5K | 0.36% | 56 |
|
|
2023
Q1 | $721K | Sell |
5,580
-450
| -7% | -$58.1K | 0.35% | 61 |
|
|
2022
Q4 | $792K | Buy |
+6,030
| New | +$792K | 0.4% | 62 |
|